Search

ARG098

ARG098 (anti-Fas IgM monoclonal antibody) was studied in a Phase I clinical trial in 2007 involving patients with rheumatoid arthritis.

TY027

Chlorotoxin I-131

The synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a means of targeting radiation to tumor cells in the treatment of brain cancer.

ZYCOV-D

As of August, 2020 the candidate is in Phase II clinical trials[A219758].

Amcipatricin

Amcipatricin (as amcipatricin diascorbate; SPK-843) is a water-soluble partricin derivative patented by SPA Societa Prodotti Antibiotici S.p.A. and developed by Aparts and Kaken for the potential treatment

Endostatin

Mepiprazole

It acts as a 5-HT2A and α1-adrenergic receptor antagonist, and has also been shown to inhibit the reuptake and induce the release of serotonin, dopamine, and norepinephrine to varying extents.

Surotomycin

It is a benzenebutanoic acid derivative patented by Cubist Pharmaceuticals, Inc. as antibacterial agents for the treatment of Gram-positive infections.

Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins

Lipoaspiration, also known as liposuction, is a possible method for extraction. This is followed by purification and expansion of the cells in vitro.

Rozanolixizumab

[A260192] As a result, the main clinical manifestation of myasthenia gravis is easily fatigable or persistent muscle weakness.